Related Experiment Videos
Machine Learning Applications for Risk Stratification in Heart Failure with Preserved Ejection Fraction: A New Era in
1Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
Diagnostics (Basel, Switzerland)
|May 27, 2026
Summary
Machine learning (ML) improves risk prediction for heart failure with preserved ejection fraction (HFpEF) by analyzing complex data. This approach offers better patient stratification and personalized treatment strategies for HFpEF.
Area of Science:
- Cardiology
- Artificial Intelligence
- Biomedical Informatics
Background:
- Heart failure with preserved ejection fraction (HFpEF) is a common and complex condition with limited treatment options.
- Current risk stratification tools for HFpEF have modest prognostic accuracy.
- Accurate risk stratification is crucial for managing HFpEF due to its heterogeneity.
Purpose of the Study:
- To review the application of machine learning (ML) in improving risk prediction for HFpEF.
- To highlight the potential of ML in identifying distinct HFpEF patient subgroups.
- To discuss the challenges and future directions of ML in HFpEF management.
Main Methods:
- Review of current machine learning techniques applied to HFpEF, including random forests, gradient boosting, support vector machines, and deep learning.
- Integration of multidimensional data: clinical, imaging, biomarker, and molecular data.
- Analysis of ML model performance in discrimination and subgroup identification.
Main Results:
- Machine learning models demonstrate superior discrimination compared to traditional scores for HFpEF.
- ML algorithms can identify unique phenotypic subgroups within HFpEF with different outcomes.
- ML facilitates a more nuanced understanding of HFpEF complexity.
Conclusions:
- Machine learning offers significant potential to enhance risk stratification and personalized care in HFpEF.
- Addressing challenges like data bias and interpretability is key for clinical integration.
- Future ML applications may include real-time decision support and guiding personalized therapies for HFpEF.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...